Excess body weight puts stress on the joints, increasing risk of fractures, but weight loss from calorie restriction is associated with reductions in bone mineral density (BMD) with increased bone turnover
Emerging research into Semaglutides central nervous system biology
But in reality: They were obese a year ago (BMI 32) Lost around 14kg using GLP-1s from a D2C provider (no detail on their electronic health record) Still have underlying metabolic syndrome If we assume about 65% of people who start GLP-1 medications quit by the end of year one, that creates a big problem
Most KLOW research protocols span 8 to 16 weeks with gradual dose titration, depending on the study endpoint
Monitoring your weight weekly during the first 12 weeks after stopping helps you catch regain early and adjust diet and exercise before substantial weight returns
After you eat on semaglutide, it almost feels like you went to Sparrow Wolf in Spring Valley, CA and ate to your heart's content